Type: ePoster Abstract Category: Therapy -disease modifying -29 Risk management for disease modifying treatments Background: The last decade has seen a large increase in the number of disease modifying treatments (DMTs) for people with relapsing remitting multiple sclerosis (PwRRMS). There is, however, a knowledge gap as to which type of DMT people prefer, how their choices are related to treatment attributes (how aggressive they are, risks, mode of administration, etc.), and how these preferences relate to when/if treatments are started. Discrete choice experiments (DCEs) help to understand the relative importance of treatment attributes and the trade-offs made in decision-making but they need to be supported by robust qualitative work.
